Patents by Inventor Stephan Grissmer

Stephan Grissmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 5-alkoxypsoralens as inhibitors of potassium channel activity in lymphocytes and other cells
    Patent number: 7772408
    Abstract: Compositions of matter comprising 5-phenylalkoxypsoralen compounds and their method of synthesis and use. The compounds are useable to treat diseases or disorders in human or veterinary patients, including autoimmune diseases such as multiple sclerosis. The compounds inhibit potassium channels, including the Kv1.3 channel and at least some of the therapeutic effects of such compounds may be due at least in part to potassium channel inhibition.
    Type: Grant
    Filed: August 29, 2003
    Date of Patent: August 10, 2010
    Assignee: The Regents of the University of California
    Inventors: Julia Vennekamp, Heike Wulff, K. George Chandy, Stephan Grissmer, Wolfram Hansel
  • Assay, methods and products based on n K.sup.+ channel expression
    Patent number: 5827655
    Abstract: This disclosure relates to the n K.sup.+ channel expression product of the MK3 gene or a functionally bioactive equivalent thereof and its uses, particulary in combination with identifying immune responses and materials modulating or blocking same.
    Type: Grant
    Filed: September 12, 1995
    Date of Patent: October 27, 1998
    Assignee: The Regents of the University of California
    Inventors: Kanianthara G. Chandy, Michael D. Cahalan, Stephan Grissmer, Alan L. Goldin, Brent A. Dethlefs, George A. Gutman, John J. Wasmuth
  • Assay for and treatment of autoimmune diseases
    Patent number: 5397702
    Abstract: This disclosure relates to the general diagnosis and treatment of autoimmune diseases with materials identified in assays based upon the finding herein that such diseases manifest by elevated numbers of type l K.sup.+ channels in abnormal CD4.sup.- CD8.sup.- T cells.
    Type: Grant
    Filed: October 2, 1992
    Date of Patent: March 14, 1995
    Assignee: The Regents of the University of California
    Inventors: Michael D. Cahalan, Kanianthara G. Chandy, Stephan Grissmer, Sanjiu Ghanshani, George A. Gutman, Brent A. Dethlefs